Dachaigh › Cairtean uaine › Invagen Pharmaceuticals, Inc.
Invagen Pharmaceuticals, Inc.: sponsorachadh cairt uaine (PERM)
Chuir Invagen Pharmaceuticals, Inc. 4 iarrtasan dearbhaidh obrach PERM a chaidh a dhearbhadh ann am bliadhnaichean ionmhais 2024–2026; dearbhte: 4. Tuarastal meadhanach tairgte $77,886; ùine mheadhanach bhon chur-a-steach chun dearbhadh: 488 làithean.
Tuarastalan H-1B aig Invagen Pharmaceuticals, Inc. →
Tiotalan dreuchd
| Tiotal dreuchd | Iarrtasan PERM | Tuarastal meadhanach |
|---|---|---|
| QC and Lab Safety Specialist | 1 | $72,842 |
| Production Planning Analyst, Pharmaceuticals | 1 | $77,397 |
| Project Management Lead, R&D | 1 | $129,688 |
| QC Chemist III | 1 | $78,374 |
Làraich obrach
Gnìomhan
Co-dhùnaidhean as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Air a cho-dhùnadh | Inbhe | Làithean |
|---|---|---|---|---|---|---|
| QC Chemist III | $78,374–$96,000 | Central lslip, NY | 6 Màrt 2025 | 20 Cèit 2026 | Dearbhte | 440 |
| Project Management Lead, R&D | $129,688–$130,000 | Central lslip, NY | 9 Dàmh 2024 | 12 Màrt 2026 | Dearbhte | 519 |
| Production Planning Analyst, Pharmaceuticals | $77,397 | Central Islip, NY | 17 Dàmh 2023 | 7 Màrt 2025 | Dearbhte, a’ dol seachad | 507 |
| QC and Lab Safety Specialist | $72,842 | Hauppauge, NY | 28 Sult 2023 | 10 Faoi 2025 | Dearbhte, a’ dol seachad | 470 |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; bidh na staitistigean a’ cleachdadh iarrtasan làn-ùine teisteanasach. Is e teisteanas PERM aon cheum a dh’ionnsaigh caird-uaine; bidh USCIS a’ co-dhùnadh an ath-thagraidh. Chan e comhairle laghail a th’ ann. Stòr: Roinn Obrach nan SA, Dàta Foillseachaidh OFLC PERM, bliadhnaichean ionmhais 2024–2026 (co-dhùnadh as ùire 30 Ògmh 2026).